Hanna Bayer

7 papers · 419 indexed citations

Immediate Impact

5 from Science/Nature 70 hit

Sub-graph 1 of 21

Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease

2025 HitNature

Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances

2025 Hit

1 intermediate paper

Comparison of Sirtuin 3 Levels in ALS and Huntington’s Disease—Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models

2017

Mutual exacerbation of peroxisome proliferator‐activated receptor γ coactivator 1α deregulation and α‐synuclein oligomerization

2014

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Hanna Bayer	194	158	128	117	106	7	419
Cristina Gómez-Santos	209 1.1×	153 1.0×	149 1.2×	68 0.6×	60 0.6×	8	421
K Matsuura	199 1.0×	116 0.7×	171 1.3×	80 0.7×	101 1.0×	10	438
Ji‐Dong Guo	105 0.5×	160 1.0×	157 1.2×	95 0.8×	50 0.5×	8	437
Janani Parameswaran	159 0.8×	200 1.3×	128 1.0×	104 0.9×	99 0.9×	10	419
Jeremy D. Burgess	170 0.9×	184 1.2×	80 0.6×	164 1.4×	69 0.7×	17	473
Xiao‐Liang Liu	124 0.6×	181 1.1×	71 0.6×	53 0.5×	46 0.4×	9	401
Yunlan Du	154 0.8×	168 1.1×	128 1.0×	123 1.1×	69 0.7×	13	459
Stephanie L. Celano	263 1.4×	139 0.9×	139 1.1×	106 0.9×	62 0.6×	6	448
Valentín Cóppola-Segovia	131 0.7×	120 0.8×	109 0.9×	141 1.2×	110 1.0×	8	421
Uttam Ojha	109 0.6×	172 1.1×	79 0.6×	74 0.6×	45 0.4×	10	388

Loading papers...